Inari Medical [NARI] vs Boston Scientific [BSX] Detailed Stock Comparison

Inari Medical Inc.

NASDAQ

Boston Scientific Corporation

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Inari Medical Inc. wins in 1 metrics, Boston Scientific Corporation wins in 14 metrics, with 0 ties. Boston Scientific Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Inari Medical Inc.	Boston Scientific Corporation	Better
P/E Ratio (TTM)	-2,665.67	27.49	Boston Scientific Corporation
Price-to-Book Ratio	10.75	4.02	Boston Scientific Corporation
Debt-to-Equity Ratio	7.53	48.92	Inari Medical Inc.
PEG Ratio	571.21	0.29	Boston Scientific Corporation
EV/EBITDA	-176.14	19.85	Boston Scientific Corporation
Profit Margin (TTM)	-13.68%	17.29%	Boston Scientific Corporation
Operating Margin (TTM)	-4.34%	21.55%	Boston Scientific Corporation
EBITDA Margin (TTM)	N/A	21.55%	N/A
Return on Equity	-17.72%	11.84%	Boston Scientific Corporation
Return on Assets (TTM)	-3.21%	6.64%	Boston Scientific Corporation
Free Cash Flow (TTM)	N/A	$3.40B	N/A
1-Year Return	N/A	-52.97%	N/A
Price-to-Sales Ratio (TTM)	8.15	4.74	Boston Scientific Corporation
Enterprise Value	$4.60B	$107.72B	Boston Scientific Corporation
EV/Revenue Ratio	8.01	5.23	Boston Scientific Corporation
Gross Profit Margin (TTM)	87.06%	N/A	N/A
Revenue per Share (TTM)	$10	$14	Boston Scientific Corporation
Earnings per Share (Diluted)	$-1.35	$2.39	Boston Scientific Corporation
Beta (Stock Volatility)	1.03	0.78	Boston Scientific Corporation
Short % of Float	N/A	1.58%	N/A

Inari Medical Inc. vs Boston Scientific Corporation Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Inari Medical Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Boston Scientific Corporation	-0.32%	-3.98%	-11.24%	-33.00%	-49.28%	-50.63%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Inari Medical Inc.	N/A	N/A	N/A	N/A	N/A	N/A
Boston Scientific Corporation	-52.97%	-13.64%	9.04%	108.58%	590.87%	133.50%

Performance & Financial Health Analysis: Inari Medical Inc. vs Boston Scientific Corporation

Metric	NARI	BSX
Market Information
Market Cap i	$4.68B	$97.63B
Market Cap Category	Mid cap	Large cap
10 Day Avg. Volume i	1,052,478	18,916,072
90 Day Avg. Volume i	3,170,369	16,730,711
Last Close	$79.97	$46.76
52 Week Range	$36.73 - $79.99	$45.99 - $109.50
% from 52W High	-0.02%	-57.30%
All-Time High	$79.97 (Feb 19, 2025)	$109.50 (Sep 09, 2025)
% from All-Time High	0.00%	-57.30%
Growth Metrics
Quarterly Revenue Growth	0.21%	0.12%
Quarterly Earnings Growth	N/A	0.99%
Financial Health
Profit Margin (TTM) i	-0.14%	0.17%
Operating Margin (TTM) i	-0.04%	0.22%
Return on Equity (TTM) i	-0.18%	0.12%
Debt to Equity (MRQ) i	7.53	48.92
Cash & Liquidity
Book Value per Share (MRQ)	$7.44	$16.34
Cash per Share (MRQ)	$1.91	$1.32
Operating Cash Flow (TTM) i	$14.18M	$4.50B
Levered Free Cash Flow (TTM) i	$86.61M	$10.53B
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Inari Medical Inc. vs Boston Scientific Corporation

Metric	NARI (Mar 31, 2025)	BSX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i	-2,665.67	27.49
Forward P/E i	571.21	17.29
PEG Ratio i	571.21	0.29
Price to Sales (TTM) i	8.15	4.74
Price to Book (MRQ) i	10.75	4.02
Market Capitalization
Market Capitalization i	$4.68B	$97.63B
Enterprise Value i	$4.60B	$107.72B
Enterprise Value Metrics
Enterprise to Revenue i	8.01	5.23
Enterprise to EBITDA i	-176.14	19.85
Risk & Other Metrics
Beta i	1.03	0.78
Book Value per Share (MRQ) i	$7.44	$16.34

Financial Statements Comparison: Inari Medical Inc. vs Boston Scientific Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric	NARI (2023)	BSX (2025)
Revenue/Sales i	493.63M	20.07B
Cost of Goods Sold i	59.07M	6.22B
COGS % of Revenue i	12.0%	31.0%
Gross Profit i	434.56M	13.85B
Gross Margin i	88.0%	69.0%
Research & Development i	87.53M	2.05B
Operating Income (EBIT) i	-14.03M	3.97B
Operating Margin i	-2.8%	19.8%
EBITDA i	15.18M	5.33B
EBITDA Margin i	3.1%	26.6%
Pre-Tax Income i	4.25M	3.39B
Pre-Tax Income % of Revenue i	0.9%	16.9%
Income Tax i	5.88M	493.00M
Income Tax % of Revenue i	1.2%	2.5%
Net Income (Profit) i	-1.64M	2.89B
Profit Margin i	-0.3%	14.4%

Balance Sheet & Liquidity Metrics

Metric	NARI (2023)	BSX (2025)
Cash & Equivalents i	38.60M	1.97B
Total Current Assets i	235.56M	8.79B
Total Current Assets % of Revenue i	47.7%	43.8%
Total Current Liabilities i	76.34M	5.44B
Total Current Liabilities % of Revenue i	15.5%	27.1%
Long-Term Debt i	30.36M	11.14B
Long-Term Debt % of Revenue i	6.1%	55.5%
Total Shareholders Equity i	464.91M	24.47B
Retained Earnings i	-48.49M	5.57B
Retained Earnings % of Revenue i	-9.8%	27.8%
Property, Plant & Equipment i	65.06M	0

Cash Flow Statement Comparison

Metric	NARI (2023)	BSX (2025)
Operating Cash Flow i	N/A	4.50B
Operating Cash Flow % of Revenue i	0.0%	22.4%
Capital Expenditures i	N/A	-876.00M
Free Cash Flow i	N/A	3.40B
FCF Margin i	0.0%	17.0%
Debt Repayment i	N/A	-2.05B
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	NARI	BSX
Shares Short i	N/A	23.53M
Short Ratio i	N/A	1.59
Short % of Float i	N/A	1.58%
Shares Outstanding i	57.76M	1.49B
Float Shares i	53.34M	1.48B
% Held by Insiders i	9.00%	0.21%
% Held by Institutions i	95.56%	95.16%
% Held by Public i	-4.56%	4.63%

Dividend Analysis & Yield Comparison: Inari Medical Inc. vs Boston Scientific Corporation

Metric	NARI	BSX
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Metric	NARI (Sep 30, 2024)	BSX (Dec 31, 2025)
Revenue/Sales i	153.39M	5.29B
Cost of Goods Sold i	19.85M	1.61B
COGS % of Revenue i	12.9%	30.4%
Gross Profit i	133.54M	3.68B
Gross Margin i	87.1%	69.6%
Research & Development i	29.43M	569.00M
Operating Income (EBIT) i	-6.66M	1.04B
Operating Margin i	-4.3%	19.7%
EBITDA i	-304,000	1.25B
EBITDA Margin i	-0.2%	23.6%
Pre-Tax Income i	-12.67M	700.00M
Pre-Tax Income % of Revenue i	-8.3%	13.2%
Income Tax i	5.70M	30.00M
Income Tax % of Revenue i	3.7%	0.6%
Net Income (Profit) i	-18.37M	670.00M
Profit Margin i	-12.0%	12.7%

Inari Medical [NARI] vs Boston Scientific [BSX] Detailed Stock Comparison

Inari Medical Inc.

Boston Scientific Corporation

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Inari Medical Inc. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Inari Medical Inc. vs Boston Scientific Corporation Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Inari Medical Inc. vs Boston Scientific Corporation

Valuation & Enterprise Metrics Analysis: Inari Medical Inc. vs Boston Scientific Corporation

Financial Statements Comparison: Inari Medical Inc. vs Boston Scientific Corporation

Financial Metrics

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

NARI (Annual)

NARI (Quarterly)

BSX (Annual)

BSX (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Inari Medical Inc. vs Boston Scientific Corporation

Metric	NARI (Sep 30, 2024)	BSX (Dec 31, 2025)
Cash & Equivalents i	41.14M	1.97B
Total Current Assets i	263.39M	8.79B
Total Current Assets % of Revenue i	171.7%	166.4%
Total Current Liabilities i	148.78M	5.44B
Total Current Liabilities % of Revenue i	97.0%	102.9%
Long-Term Debt i	31.15M	11.14B
Long-Term Debt % of Revenue i	20.3%	210.7%
Total Shareholders Equity i	434.76M	24.47B
Retained Earnings i	-122.40M	5.57B
Retained Earnings % of Revenue i	-79.8%	105.4%
Property, Plant & Equipment i	66.83M	0

Metric	NARI (Sep 30, 2024)	BSX (Dec 31, 2025)
Operating Cash Flow i	N/A	1.27B
Operating Cash Flow % of Revenue i	0.0%	24.0%
Capital Expenditures i	N/A	-351.00M
Free Cash Flow i	N/A	939.00M
FCF Margin i	0.0%	17.8%
Debt Repayment i	N/A	-209.00M
Common Stock Repurchase i	N/A	N/A

Inari Medical [NARI] vs Boston Scientific [BSX] Detailed Stock Comparison

Inari Medical Inc.

Boston Scientific Corporation

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Inari Medical Inc. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Inari Medical Inc. vs Boston Scientific Corporation Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Inari Medical Inc. vs Boston Scientific Corporation

Valuation & Enterprise Metrics Analysis: Inari Medical Inc. vs Boston Scientific Corporation

Financial Statements Comparison: Inari Medical Inc. vs Boston Scientific Corporation

Financial Metrics Quarterly Annual

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

NARI (Annual)

NARI (Quarterly)

BSX (Annual)

BSX (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Inari Medical Inc. vs Boston Scientific Corporation

Financial Metrics